Editas Medicine (EDIT) Accounts Payables (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Accounts Payables data on file, last reported at $2.6 million in Q4 2025.

• On a quarterly basis, Accounts Payables fell 52.58% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 52.58% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 52.58% from the prior year.
• Accounts Payables for Q4 2025 stood at $2.6 million, down from $3.2 million in the prior quarter.
• Over the last five years, Accounts Payables for EDIT reached as high as $13.8 million in Q2 2024 and fell as low as $2.6 million in Q4 2025.
• Historically, Accounts Payables has averaged $7.1 million across 5 years, with a median of $6.8 million in 2022.
• Across the five-year window, Accounts Payables soared 100.94% in 2022 and tumbled 74.68% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $5.0 million in 2021, then surged by 88.34% to $9.5 million in 2022, then declined by 13.06% to $8.3 million in 2023, then slumped by 33.57% to $5.5 million in 2024, then plunged by 52.58% to $2.6 million in 2025.
• Per Business Quant data, the three most recent Accounts Payables figures were $2.6 million in Q4 2025, $3.2 million in Q3 2025, and $6.7 million in Q2 2025.